Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

L. Erdem, E. Giovannetti, L.G. Leon, R. Honeywell, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1649-1659
JournalCurrent Topics in Medicinal Chemistry
Volume12
Issue number15
DOIs
Publication statusPublished - 2012

Cite this